Sun, Dec 21, 2014, 4:19 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Theravance Inc. Message Board

  • equityvaluation equityvaluation Feb 25, 2013 5:49 PM Flag

    ML expects favorable Breo panel, $34 PO

    THRX reiterated no new topics have been
    brought up during recent interactions that marketing partner GSK has had with
    FDA. THRX views the recent positive vote for BI’s once per day LABA olodaterol
    as a positive indicator (this same committee will review Breo), as the panelists
    focused on clinical utility of phase 3 data rather than just on the statistically
    significant lowest effective doses. Breo’s PDUFA is May12,We model $2bn in
    US Breo sales by 2015 and maintain our Buy rating and $34 PO on THRX shares

    SortNewest  |  Oldest  |  Most Replied Expand all replies
15.22-0.01(-0.03%)Dec 19 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Under Armour, Inc.
NYSEFri, Dec 19, 2014 4:04 PM EST
Hecla Mining Co.
NYSEFri, Dec 19, 2014 4:00 PM EST
ImmunoGen, Inc.
NASDAQFri, Dec 19, 2014 4:00 PM EST